세계의 뉴트라슈티컬 첨가제 시장 규모 : 기능성별, 형태별, 용도별, 최종 제품별, 지역별 범위 및 예측

Nutraceutical Excipients Market Size And Forecast

Nutraceutical Excipients Market size was valued at USD 3.79 Billion in 2024 and is projected to reach USD 6.52 Billion by 2032 growing at a CAGR of 7.01% from 2026 to 2032.

Nutraceutical excipients are inert ingredients that act as transporters or facilitators in nutraceutical compositions. They improve the transport and stability of active substances, therefore increasing bioavailability. Binders, fillers, disintegrants and lubricants are common excipients that help nutraceutical products be more effective and appealing to consumers.

Excipients are important in nutraceutical formulation because they ensure constant dosing and aid in the production process. They improve the physical qualities of products, such as flowability and solubility and can affect the release profile of active substances. The correct excipient can dramatically improve the efficacy and shelf life of nutraceutical products.

Future applications of nutraceutical excipients will concentrate on developing novel materials that improve functionality and sustainability. Advances in excipient technology may lead to more tailored delivery systems and improved compatibility with bioactive compounds. As consumer demand for personalized nutrition grows, excipients will evolve to meet diverse formulation needs, enhancing health benefits.

Global Nutraceutical Excipients Market Dynamics

Key Market Drivers:

Growing Demand for Functional Foods and Dietary Supplements: The growing consumer awareness of health and wellbeing has greatly increasing demand for functional foods and dietary supplements. As more people discover the benefits of nutritional supplementation for overall well-being, the nutraceutical excipients industry expands significantly. In 2018, 58% of American adults reported using dietary supplements, indicating a significant change toward proactive health management and a stronger emphasis on preventative treatment.

Increasing Prevalence of Chronic Diseases and An Aging Population: The rising prevalence of chronic diseases, combined with an aging population, drives greater need for preventative healthcare solutions. Diabetes, cardiovascular disease and obesity are all chronic disorders that require nutritional interventions to be managed. By 2050, the world population aged 60 and over is expected to reach 2 billion, increasing the demand for nutraceutical goods that enhance health and longevity, therefore extending the market for excipients.

Key Challenges:

Regulatory Challenges: Navigating the complicated regulatory landscape of the nutraceutical industry presents substantial obstacles to manufacturers. Product development and market access are complicated by varying legislation among countries, which can lead to delays and greater costs. Compliance with these standards is vital to guaranteeing product safety and efficacy, making it a top priority for businesses in this industry.

Formulation Complexities: To obtain the desired results, effective nutraceutical formulations must be balanced between active components and excipients. The challenges include maintaining stability, assuring bioavailability and conserving sensory properties including taste and feel. This complexity might complicate the production process, necessitating novel methodologies and rigorous testing to produce high-quality nutraceutical goods.

Consumer Skepticism: Skepticism against nutraceutical products intensifies as consumers become more informed of the safety and efficacy of its ingredients. This tendency requires manufacturers to prioritize transparency and education to build consumer trust. By addressing concerns and providing clear information, companies can overcome skepticism and enhance their market position, fostering long-term customer relationships.

Key Trends:

Clean Labeling: Customers are increasingly demanding transparency in ingredient sourcing. Manufacturers are working on natural and clean-label excipients to meet consumer demand for products free of artificial additives and preservatives.

Personalized Nutrition: The rise of personalized nutrition is driving the demand for customized nutraceutical goods. Excipients are being developed to improve the distribution and efficacy of tailored supplements, addressing individual health needs and preferences.

Innovative Delivery Systems: Technological advancements are enabling the creation of innovative delivery technologies like as nanoparticles and liposomes. These advances improve the bioavailability and targeted release of active substances, hence increasing product effectiveness.

Sustainability Focus: The nutraceutical industry is increasingly focusing on sustainability. Manufacturers are pursuing eco-friendly excipients sourced from renewable sources, boosting environmental responsibility practices in formulation and production.

Regulatory Compliance: As regulations evolve, there is a heightened focus on compliance within the nutraceutical industry. Companies are prioritizing adherence to international standards to ensure product safety and efficacy while navigating diverse regulatory environments.

Global Nutraceutical Excipients Market Regional Analysis

North America:

According to Verified Market Research, North America is expected to dominate the global nutraceutical excipients market.

North America is expected to dominate the worldwide nutraceutical excipients market. This is primarily due to increasing consumer awareness of health supplements and functional foods. The Council for Responsible Nutrition estimated that 77% of Americans used dietary supplements in 2019, up from 76% in 2018.

This increasing use of dietary items increases demand for nutraceuticals, demanding a broader range of excipients for appropriate formulation and delivery. The trend emphasizes the significance of developing unique excipient solutions to meet the changing tastes of health-conscious customers in the region.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global nutraceutical excipients market.

The Asia Pacific area is the most rapidly expanding market for nutraceutical excipients. Rapid population expansion and rising disposable incomes are boosting demand for nutraceutical products in this region. The United Nations predicts that the population will increase from 4.3 billion in 2020 to 4.7 billion by 2050, resulting in a larger customer base.

Additionally, GDP per capita in East Asia grew from $1,977 in 2000 to $11,687 in 2021, indicating improving economic conditions. This economic expansion increases consumer expenditure on health and wellness items, hence driving up demand for nutraceuticals. As a result, manufacturers are reacting with unique excipients designed to satisfy the changing health demands of this diverse population.

Global Nutraceutical Excipients Market: Segmentation Analysis

The Global Nutraceutical Excipients Market is segmented based Functionality, Form, Application, End Product and Geography.

Nutraceutical Excipients Market, By Functionality

• Fillers & Diluents
• Coating Agents
• Flavoring Agents

Nutraceutical Excipients Market, By Form

• Dry
• Liquid

Nutraceutical Excipients Market, By Application

• Pain Management
• Education And Training
• Surgery
• Patient Care Management
• Rehabilitation
• Therapy Procedure and Post-Traumatic Stress Disorder (PTSD)

Nutraceutical Excipients Market, By End Product

• Prebiotics
• Probiotics
• Proteins & Amino Acids
• Vitamins

Nutraceutical Excipients Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Key Players

• The Global Nutraceutical Excipients Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are Air Liquide, Ashland, Associated British Foods plc, Azelis Group, BASF SE, Biogrund GmbH, Cargill, Incorporated, Hilmar Cheese Company, Inc, IMCD, Ingredion, Innophos, International Flavors & Fragrances, Inc., Kerry Group plc, MEGGLE GmbH & Co. KG, Roquette Freres, Sensient Technologies Corporation.
• Global Nutraceutical Excipients Market Recent Developments
• In June 2023, Lubrizol Corporation, a US-based corporation, announced that Carbopol(R) Polymers had received new EU food-grade approval.
• In October 2023, Lubrizol Corporation licensed its Apisolex(TM) excipient polymer technology to Welton Pharma (Welton).
• In 2023, Roquette, a French business, announced the addition of three new excipient grades to its unrivaled line of solutions for moisture-sensitive active pharmaceutical and nutraceutical ingredients.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

• 5.1 Overview
• 5.2 Fillers & Diluents
• 5.3 Coating Agents
• 5.4 Flavoring Agents

6 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT

• 6.1 Overview
• 6.2 Prebiotics
• 6.3 Probiotics
• 6.4 Proteins & Amino Acids
• 6.5 Vitamins

7 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM

• 7.1 Overview
• 7.2 Dry
• 7.3 Liquid

8 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY APPLICATION

• 8.1 Overview
• 8.2 Pain Management
• 8.3 Education And Training
• 8.4 Surgery
• 8.5 Patient Care Management
• 8.6 Rehabilitation
• 8.7 Therapy Procedure and Post-Traumatic Stress Disorder (PTSD)

9 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East

10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Air Liquide
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Ashland
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Associated British Foods plc
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Azelis Group
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 BASF SE
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Biogrund GmbH
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Cargill
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Incorporated
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 Hilmar Cheese Company, Inc
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments
• 11.10 IMCD
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments
• 11.11 Ingredion
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.12 Innophos
  • 11.12.1 Overview
  • 11.12.2 Financial Performance
  • 11.12.3 Product Outlook
  • 11.12.4 Key Developments
• 11.13 International Flavors & Fragrances, Inc.
  • 11.13.1 Overview
  • 11.13.2 Financial Performance
  • 11.13.3 Product Outlook
  • 11.13.4 Key Developments
• 11.14 Kerry Group plc
  • 11.14.1 Overview
  • 11.14.2 Financial Performance
  • 11.14.3 Product Outlook
  • 11.14.4 Key Developments
• 11.15 MEGGLE GmbH & Co. KG
  • 11.15.1 Overview
  • 11.15.2 Financial Performance
  • 11.15.3 Product Outlook
  • 11.15.4 Key Developments
• 11.16 Roquette Freres
  • 11.16.1 Overview
  • 11.16.2 Financial Performance
  • 11.16.3 Product Outlook
  • 11.16.4 Key Developments
• 11.17 Sensient Technologies Corporation
  • 11.17.1 Overview
  • 11.17.2 Financial Performance
  • 11.17.3 Product Outlook
  • 11.17.4 Key Developments

12 Appendix

• 12.1 Related Research